Free Trial

Telomir Pharmaceuticals (TELO) Institutional Ownership

Telomir Pharmaceuticals logo
$4.54 +0.31 (+7.33%)
Closing price 04:00 PM Eastern
Extended Trading
$4.28 -0.26 (-5.81%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)

Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$3.98M
Number of
Institutional Sellers
(last 12 months)
0
Get TELO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TELO Institutional Buying and Selling by Quarter

Remove Ads

Telomir Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Nuveen Asset Management LLC24,990$103K0.0%N/A0.084%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036%
2/17/2025 Gotham Asset Management LLC6,770$28K0.0%N/A0.023%
2/17/2025 Bank of America Corp DE14,713$61K0.0%+283.9%0.049%
2/14/2025 Northern Trust Corp151,628$625K0.0%+211.5%0.510%
2/14/2025 Transce3nd LLC28,803$119K0.0%N/A0.097%
2/13/2025 Barclays PLC29,959$123K0.0%+326.9%0.101%
2/13/2025 Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034%
2/12/2025 Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390%
2/12/2025 JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139%
2/11/2025 Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032%
2/11/2025 Virtu Financial LLC14,959$62K0.0%N/A0.050%
2/6/2025 Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157%
2/4/2025 Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244%
1/30/2025 Rhumbline Advisers8,600$35K0.0%+105.9%0.029%
11/19/2024 Barclays PLC7,018$45K0.0%+325.1%0.024%
11/16/2024 Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806%
11/15/2024 Barclays PLC7,018$45K0.0%+325.1%0.024%
11/15/2024 State Street Corp36,094$232K0.0%+99.1%0.122%
10/21/2024 Suncoast Equity Management51,194$329K0.0%+109.9%0.173%
8/15/2024 Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049%
7/26/2024 Bank of New York Mellon Corp50,165$241K0.0%N/A0.169%
5/2/2024 Suncoast Equity Management24,391$126K0.0%N/A0.082%
(Data available from 1/1/2016 forward)

Remove Ads

TELO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TELO shares?

During the previous two years, 18 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($298K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on TELO's institutional investors.

Which institutional investors have been buying Telomir Pharmaceuticals stock?

Of the 18 institutional investors that purchased Telomir Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($71.10K), Suncoast Equity Management ($51.19K), JPMorgan Chase & Co. ($37.98K), Charles Schwab Investment Management Inc. ($35.56K), and Barclays PLC ($33.68K).

How much institutional buying is happening at Telomir Pharmaceuticals?

Institutional investors have bought a total of 821,679 shares in the last 24 months. This purchase volume represents approximately $3.98M in transactions.



This page (NASDAQ:TELO) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners